{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:24:00Z","timestamp":1783347840436,"version":"3.54.6"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071984"],"award-info":[{"award-number":["82071984"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471894"],"award-info":[{"award-number":["82471894"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91959117"],"award-info":[{"award-number":["91959117"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Scientific Research Program of FuRong Laboratory","award":["2024PT5110"],"award-info":[{"award-number":["2024PT5110"]}]},{"name":"the Science and Technology Innovation Program of Hunan Province","award":["2020RC4007"],"award-info":[{"award-number":["2020RC4007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1245\/s10434-026-19624-y","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T19:21:02Z","timestamp":1776021662000},"page":"7767-7777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integration of Node-RADS and Habitat Radiomics for Predicting Occult Nodal Metastasis in Bladder Cancer"],"prefix":"10.1245","volume":"33","author":[{"given":"Chenyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunliang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongcui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,12]]},"reference":[{"key":"19624_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin."},{"key":"19624_CR2","doi-asserted-by":"crossref","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of bladder cancer. Med Sci Basel. 2020;8.","DOI":"10.3390\/medsci8010015"},{"key":"19624_CR3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41585-018-0066-1","volume":"15","author":"M Perera","year":"2018","unstructured":"Perera M, McGrath S, Sengupta S, Crozier J, Bolton D, Lawrentschuk N. Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer. Nat Rev Urol. 2018;15:686\u201392.","journal-title":"Nat Rev Urol."},{"key":"19624_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/1759-7714.12978","volume":"10","author":"Y Takahashi","year":"2019","unstructured":"Takahashi Y, Suzuki S, Matsutani N, Kawamura M. 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in the evaluation of clinically node-negative non-small cell lung cancer. Thorac Cancer. 2019;10:413\u201320.","journal-title":"Thorac Cancer."},{"key":"19624_CR5","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.eururo.2009.01.004","volume":"55","author":"A Karl","year":"2009","unstructured":"Karl A, Carroll PR, Gschwend JE, et al. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol. 2009;55:826\u201335.","journal-title":"Eur Urol."},{"key":"19624_CR6","doi-asserted-by":"publisher","first-page":"6052","DOI":"10.1097\/JS9.0000000000000899","volume":"110","author":"LC Chu","year":"2024","unstructured":"Chu LC, Fishman EK. Pancreatic ductal adenocarcinoma staging: a narrative review of radiologic techniques and advances. Int J Surg. 2024;110:6052\u201363.","journal-title":"Int J Surg."},{"key":"19624_CR7","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1097\/JS9.0000000000001239","volume":"110","author":"E Abbaspour","year":"2024","unstructured":"Abbaspour E, Karimzadhagh S, Monsef A, Joukar F, Mansour-Ghanaei F, Hassanipour S. Application of radiomics for preoperative prediction of lymph node metastasis in colorectal cancer: a systematic review and meta-analysis. Int J Surg. 2024;110:3795\u2013813.","journal-title":"Int J Surg."},{"key":"19624_CR8","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.233356","volume":"311","author":"JH Sohn","year":"2024","unstructured":"Sohn JH, Fields BKK. Radiomics and deep learning to predict pulmonary nodule metastasis at CT. Radiology. 2024;311:e233356.","journal-title":"Radiology."},{"key":"19624_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/jmri.28982","volume":"59","author":"T Xia","year":"2024","unstructured":"Xia T, Zhao B, Li B, et al. MRI-based radiomics and deep learning in biological characteristics and prognosis of hepatocellular carcinoma: opportunities and challenges. JMRI J Magnetic Resonance Imaging. 2024;59:767\u201383.","journal-title":"JMRI J Magnetic Resonance Imaging."},{"key":"19624_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s12519-024-00823-0","volume":"20","author":"F Pacchiano","year":"2024","unstructured":"Pacchiano F, Tortora M, Doneda C, et al. Radiomics and artificial intelligence applications in pediatric brain tumors. World J Pediatr. 2024;20:747\u201363.","journal-title":"World J Pediatr."},{"key":"19624_CR11","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232092","volume":"310","author":"S Du","year":"2024","unstructured":"Du S, Gao S, Wang M, Zhang L. Multiparametric MRI radiomics for the identification of HER2-low breast cancers. Radiology. 2024;310:e232092.","journal-title":"Radiology."},{"key":"19624_CR12","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1007\/s00330-021-08426-3","volume":"32","author":"G Zhang","year":"2022","unstructured":"Zhang G, Wu Z, Zhang X, et al. CT-based radiomics to predict muscle invasion in bladder cancer. Eur Radiol. 2022;32:3260\u20138.","journal-title":"Eur Radiol."},{"key":"19624_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1148\/radiol.13122697","volume":"269","author":"RA Gatenby","year":"2013","unstructured":"Gatenby RA, Grove O, Gillies RJ. Quantitative imaging in cancer evolution and ecology. Radiology. 2013;269:8\u201315.","journal-title":"Radiology."},{"key":"19624_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12967-024-06057-y","volume":"23","author":"Y Wu","year":"2025","unstructured":"Wu Y, Zhang W, Liang X, et al. Habitat radiomics analysis for progression free survival and immune-related adverse reaction prediction in non-small cell lung cancer treated by immunotherapy. J Translat Med. 2025;23:393.","journal-title":"J Translat Med."},{"key":"19624_CR15","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1186\/s12967-024-05897-y","volume":"22","author":"J Gong","year":"2024","unstructured":"Gong J, Lu J, Zhang W, et al. A CT-based subregional radiomics nomogram for predicting local recurrence-free survival in esophageal squamous cell cancer patients treated by definitive chemoradiotherapy: a multicenter study. J Translat Med. 2024;22:1108.","journal-title":"J Translat Med."},{"key":"19624_CR16","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.2020190218","volume":"2","author":"W Mu","year":"2020","unstructured":"Mu W, Liang Y, Hall LO, et al. (18)F-FDG PET\/CT habitat radiomics predicts outcome of patients with cervical cancer treated with chemoradiotherapy. Radiol Artif Intell. 2020;2:e190218.","journal-title":"Radiol Artif Intell."},{"key":"19624_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40644-025-00842-8","volume":"25","author":"P Chen","year":"2025","unstructured":"Chen P, Yang Z, Ning P, et al. To accurately predict lymph node metastasis in patients with mass-forming intrahepatic cholangiocarcinoma by using CT radiomics features of tumor habitat subregions. Cancer Imaging. 2025;25:19.","journal-title":"Cancer Imaging."},{"key":"19624_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1148\/radiol.2018172462","volume":"288","author":"J Wu","year":"2018","unstructured":"Wu J, Cao G, Sun X, et al. Intratumoral spatial heterogeneity at perfusion MR imaging predicts recurrence-free survival in locally advanced breast cancer treated with neoadjuvant chemotherapy. Radiology. 2018;288:26\u201335.","journal-title":"Radiology."},{"key":"19624_CR19","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.1007\/s00330-020-07572-4","volume":"31","author":"FHJ Elsholtz","year":"2021","unstructured":"Elsholtz FHJ, Asbach P, Haas M, et al. Introducing the node reporting and data system 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer. Eur Radiol. 2021;31:6116\u201324.","journal-title":"Eur Radiol."},{"key":"19624_CR20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s00345-025-06047-9","volume":"43","author":"S Li","year":"2025","unstructured":"Li S, Zhang J, Cheng C, Dai Y, Liao W. Utility of node-RADS in preoperatively detecting pelvic lymph node metastasis in bladder cancer. World J Urol. 2025;43:676.","journal-title":"World J Urol."},{"key":"19624_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s12967-025-06474-7","volume":"23","author":"X Chen","year":"2025","unstructured":"Chen X, Jiang H, Pan M, et al. Habitat radiomics predicts occult lymph node metastasis and uncovers immune microenvironment of head and neck cancer. J Translat Med. 2025;23:498.","journal-title":"J Translat Med."},{"key":"19624_CR22","doi-asserted-by":"publisher","first-page":"17085","DOI":"10.1038\/s41598-025-02181-x","volume":"15","author":"X Huang","year":"2025","unstructured":"Huang X, Huang X, Wang K, Bai H, Ye B, Jin G. Habitat-based radiomics from contrast-enhanced CT and clinical data to predict lymph node metastasis in clinical N0 peripheral lung adenocarcinoma \u22643 cm. Sci Rep. 2025;15:17085.","journal-title":"Sci Rep."},{"key":"19624_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13244-025-01969-9","volume":"16","author":"P Jia","year":"2025","unstructured":"Jia P, Li Y, Li H, et al. Habitat radiomics assists radiologists in accurately diagnosing lymph node metastasis of adenocarcinoma of the esophagogastric junction. Insights Imaging. 2025;16:90.","journal-title":"Insights Imaging."},{"key":"19624_CR24","doi-asserted-by":"crossref","unstructured":"Peng Q, Zhou S, Chen R, et al. CT-Based habitat radiomics combining multi-instance learning for early prediction of post-neoadjuvant lymph node metastasis in esophageal squamous cell carcinoma. Bioengineering Basel Switzerland. 2025;12.","DOI":"10.3390\/bioengineering12080813"},{"key":"19624_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/jmri.29796","volume":"62","author":"S Chen","year":"2025","unstructured":"Chen S, Zhang Y, Su Y, et al. Habitat radiomics based on dynamic contrast-enhanced magnetic resonance imaging for assessing axillary lymph node burden in clinical T1\u2013T2 stage breast cancer: a multicenter and interpretable study. JMRI J Magnetic Resonance Imaging. 2025;62:751\u201364.","journal-title":"JMRI J Magnetic Resonance Imaging."},{"key":"19624_CR26","doi-asserted-by":"crossref","unstructured":"Wang Y, Liang W, Han P, Ye T, Hao M, Gao M. Ultrasound habitat radiomics plus clinical features for pre-operative prediction of sentinel lymph node metastasis in breast cancer. J Ultrasound Med. 2025.","DOI":"10.1002\/jum.70129"},{"key":"19624_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40644-024-00758-9","volume":"24","author":"S Li","year":"2024","unstructured":"Li S, Dai Y, Chen J, Yan F, Yang Y. MRI-based habitat imaging in cancer treatment: current technology, applications, and challenges. Cancer Imaging. 2024;24:107.","journal-title":"Cancer Imaging."},{"key":"19624_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13244-025-01956-0","volume":"16","author":"J Shen","year":"2025","unstructured":"Shen J, Li Q, Li L, et al. Contrast-enhanced MRI-based intratumoral heterogeneity assessment for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma. Insights Imaging. 2025;16:76.","journal-title":"Insights Imaging."},{"key":"19624_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.acra.2024.09.036","volume":"32","author":"H Li","year":"2025","unstructured":"Li H, Sui Y, Tao Y, et al. Coupling habitat radiomic analysis with the diversification of the tumor ecosystem: illuminating new strategy in the assessment of postoperative recurrence of non-muscle invasive bladder cancer. Acad Radiol. 2025;32:821\u201333.","journal-title":"Acad Radiol."},{"key":"19624_CR30","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.230547","volume":"6","author":"H Sagreiya","year":"2024","unstructured":"Sagreiya H. Finding the pieces to treat the whole: using radiomics to identify tumor habitats. Radiol Artif Intell. 2024;6:e230547.","journal-title":"Radiol Artif Intell."},{"key":"19624_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/JU.0000000000003981","volume":"212","author":"J Holzbeierlein","year":"2024","unstructured":"Holzbeierlein J, Bixler BR, Buckley DI, et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/SUO guideline (2017; amended 2020, 2024). J Urol. 2024;212:3\u201310.","journal-title":"J Urol."},{"key":"19624_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carri\u00f3n A, et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol. 2024;85:17\u201331.","journal-title":"Eur Urol."},{"key":"19624_CR33","unstructured":"Clark PE, Spiess PE, Agarwal N, et al. NCCN guidelines insights: bladder cancer, version 2.2016. JNCCN J Natl Comp Cancer Netwk. 2016;14:1213\u201324."},{"key":"19624_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1056\/NEJMoa022148","volume":"349","author":"HB Grossman","year":"2003","unstructured":"Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349:859\u201366.","journal-title":"N Engl J Med."},{"key":"19624_CR35","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1001\/jamaoncol.2018.3542","volume":"4","author":"CC Peyton","year":"2018","unstructured":"Peyton CC, Tang D, Reich RR, et al. Downstaging and survival outcomes associated with neoadjuvant chemotherapy regimens among patients treated with cystectomy for muscle-invasive bladder cancer. JAMA Oncol. 2018;4:1535\u201342.","journal-title":"JAMA Oncol."},{"key":"19624_CR36","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.eururo.2013.06.049","volume":"65","author":"F Petrelli","year":"2014","unstructured":"Petrelli F, Coinu A, Cabiddu M, Ghilardi M, Vavassori I, Barni S. Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis. Eur Urol. 2014;65:350\u20137.","journal-title":"Eur Urol."},{"key":"19624_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/bju.12447","volume":"114","author":"LS Mertens","year":"2014","unstructured":"Mertens LS, Meijer RP, Meinhardt W, et al. Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone. BJU Int. 2014;114:67\u201374.","journal-title":"BJU Int."},{"key":"19624_CR38","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1200\/JCO.18.01148","volume":"36","author":"A Necchi","year":"2018","unstructured":"Necchi A, Anichini A, Raggi D, et al. Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study. J Clin Oncol. 2018;36:3353\u201360.","journal-title":"J Clin Oncol."},{"key":"19624_CR39","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.eururo.2022.04.013","volume":"82","author":"B Szabados","year":"2022","unstructured":"Szabados B, Kockx M, Assaf ZJ, et al. Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder. Eur Urol. 2022;82:212\u201322.","journal-title":"Eur Urol."},{"issue":"627","key":"19624_CR40","first-page":"e613","volume":"76","author":"SJ Choi","year":"2021","unstructured":"Choi SJ, Park KJ, Heo C, Park BW, Kim M, Kim JK. Radiomics-based model for predicting pathological complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Clin Radiol. 2021;76(627):e613\u201321.","journal-title":"Clin Radiol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19624-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19624-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19624-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:38:06Z","timestamp":1783345086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19624-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["19624"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19624-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,12]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}